839-21553-18982 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-21
Dose 1 — Pfizer-BioNTech
2021-05-13
Dose 2 — Pfizer-BioNTech
2022-01-06
Dose 3 — Moderna
2022-01-18
Registered in v-safe
2022-01-18
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2022-01-20
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2022-01-27
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2022-02-03
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2022-02-10
Survey response — day 35, dose 3
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: COVID-19

MedDRA releases: 2024-11 · check-in free text available
2022-02-17
Survey response — day 42, dose 3
MedDRA: Complication of pregnancy, Office visit — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Symptoms: Pregnancy complications · Healthcare visit (other): Labor and delivery

MedDRA releases: 2024-11 · check-in free text available
2022-02-17
Report sent to call center — day 42, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-02-22
Call 1 — Left Voicemail
2022-04-08
Survey response — 3 months, dose 3
MedDRA: Influenza like illness — Feeling: Fair

Free text: Flu-like illness

MedDRA releases: 2024-11 · check-in free text available
2022-07-09
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-01-08
Survey response — 12 months, dose 3
MedDRA: Respiratory disorder, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-21	Pfizer-BioNTech	No
2	2021-05-13	Pfizer-BioNTech	No
3	2022-01-06	Moderna	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 11 — day 35, dose 3

2022-02-10

Symptoms: COVID-19

Release 11 — day 42, dose 3

2022-02-17

Symptoms: Pregnancy complications

Healthcare visit (other): Labor and delivery

Release 11 — 3 months, dose 3

2022-04-08

Symptoms: Flu-like illness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	·	·	✓
SD	Complication of pregnancy	·	·	✓
SD	COVID-19	·	·	✓
SD	Influenza like illness	·	·	✓
SD	Respiratory disorder	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release